Simurosertib
Simurosertib Uses, Dosage, Side Effects, Food Interaction and all others data.
Simurosertib is under investigation in clinical trial NCT03261947 (A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors).
| Trade Name | Simurosertib |
| Generic | Simurosertib |
| Simurosertib Other Names | Simurosertib |
| Type | |
| Formula | C17H19N5OS |
| Weight | Average: 341.43 Monoisotopic: 341.131031426 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Simurosertib
